Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Polycarpou-Schwarz, T. Gutschner, S. Grund, A. Warth, H. Zabeck, C. Hildenbrand, M. Baas, M. Meister, T. Muley, P. Schirmacher, H. Hoffmann, P. Schnabel, S. Diederichs (Heidelberg, Germany). Non-coding RNA as functional player and molecular marker in lung cancer. Eur Respir J 2011; 38: Suppl. 55, 1959

Member's Comments

Wiewrodt Rainer - 27.11.2011 10:49
Very nice!

Related content which might interest you: Identifying a tissue specific microRNA molecular signature in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 DNA methylation markers of surfactant proteins in lung cancer Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 MicroRNAs in human lung cancer and human lung embryogenesis Source: Eur Respir J 2007; 30: Suppl. 51, 428s Year: 2007 Causal RNA signatures in lung adenocarcinoma Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Polymorphisms in telomere maintenance genes and risk of lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients? Source: Eur Respir J 2015; 46: 1548-1550 Year: 2015 Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 Where next for lung cancer gene expression profiling? Source: Eur Respir J 2007; 30: 5-6 Year: 2007 Differential expression analysis of lncRNA in different types of lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: ERS Lung Science Conference 2021 Year: 2021 Lung cancer biomarkers based on miRNA Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Telomerase activity as a prognostic marker in non small cell lung cancer Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Identification of reference genes in lung cancer from RNA-seq data Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Gene regulation of apoptosis and telomere length in COPD and lung cancer Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Fusion transcripts in lung cancer Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017